Cargando…

Impact de la pandémie de COVID-19 sur les prises en charge pour cancer du sein et gynécologique

INTRODUCTION: During the COVID-19 pandemic, the containment measures and the recommendations of several societies in oncology may have impacted the request for initial care for cancers. METHODS: In this monocentric retrospective study, the number and the characteristics of patients received for a fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gosset, Marie, Gal, Jocelyn, Schiappa, Renaud, Dejode, Magali, Fouché, Yves, Alazet, Fanny, Roux, Emilie, Delpech, Yann, Barranger, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société Française du Cancer. Published by Elsevier Masson SAS. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690308/
https://www.ncbi.nlm.nih.gov/pubmed/33358012
http://dx.doi.org/10.1016/j.bulcan.2020.10.013
_version_ 1783614044401303552
author Gosset, Marie
Gal, Jocelyn
Schiappa, Renaud
Dejode, Magali
Fouché, Yves
Alazet, Fanny
Roux, Emilie
Delpech, Yann
Barranger, Emmanuel
author_facet Gosset, Marie
Gal, Jocelyn
Schiappa, Renaud
Dejode, Magali
Fouché, Yves
Alazet, Fanny
Roux, Emilie
Delpech, Yann
Barranger, Emmanuel
author_sort Gosset, Marie
collection PubMed
description INTRODUCTION: During the COVID-19 pandemic, the containment measures and the recommendations of several societies in oncology may have impacted the request for initial care for cancers. METHODS: In this monocentric retrospective study, the number and the characteristics of patients received for a first consultation for a breast or gynecologic tumor were compared between the containment period and a control period. The times from diagnosis to treatment and the type of initial care were compared too. RESULTS: During the outbreak, 91 patients were seen for a new request, versus 159 during the control period, a decrease of 43.5 %. Patients were older (62.9 versus 60.9 years old) but this difference was not significant. Tumor stage was not modified. Concerning senology, the time from the biopsy to the first consultation was 5.5 days longer during the outbreak (difference statistically insignificant). Among the 51 patients requiring a surgical treatment during the outbreak, 16 (31.48 %) were postponed after the end of the containment measures. After all, the average time from the consultation to the treatment was not modified. No modification of type of treatment was observed. DISCUSSION: At the height of the pandemic, benefits and risks of the cancer treatment had to be daily balanced against the risk of exposition to the COVID-19. The evaluation of practices for cancer care is essential to understand the real impact of COVID-19 outbreak on global cancer management, so as to get prepared to further crises.
format Online
Article
Text
id pubmed-7690308
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Société Française du Cancer. Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-76903082020-11-27 Impact de la pandémie de COVID-19 sur les prises en charge pour cancer du sein et gynécologique Gosset, Marie Gal, Jocelyn Schiappa, Renaud Dejode, Magali Fouché, Yves Alazet, Fanny Roux, Emilie Delpech, Yann Barranger, Emmanuel Bull Cancer Article Original INTRODUCTION: During the COVID-19 pandemic, the containment measures and the recommendations of several societies in oncology may have impacted the request for initial care for cancers. METHODS: In this monocentric retrospective study, the number and the characteristics of patients received for a first consultation for a breast or gynecologic tumor were compared between the containment period and a control period. The times from diagnosis to treatment and the type of initial care were compared too. RESULTS: During the outbreak, 91 patients were seen for a new request, versus 159 during the control period, a decrease of 43.5 %. Patients were older (62.9 versus 60.9 years old) but this difference was not significant. Tumor stage was not modified. Concerning senology, the time from the biopsy to the first consultation was 5.5 days longer during the outbreak (difference statistically insignificant). Among the 51 patients requiring a surgical treatment during the outbreak, 16 (31.48 %) were postponed after the end of the containment measures. After all, the average time from the consultation to the treatment was not modified. No modification of type of treatment was observed. DISCUSSION: At the height of the pandemic, benefits and risks of the cancer treatment had to be daily balanced against the risk of exposition to the COVID-19. The evaluation of practices for cancer care is essential to understand the real impact of COVID-19 outbreak on global cancer management, so as to get prepared to further crises. Société Française du Cancer. Published by Elsevier Masson SAS. 2021-01 2020-11-26 /pmc/articles/PMC7690308/ /pubmed/33358012 http://dx.doi.org/10.1016/j.bulcan.2020.10.013 Text en © 2020 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article Original
Gosset, Marie
Gal, Jocelyn
Schiappa, Renaud
Dejode, Magali
Fouché, Yves
Alazet, Fanny
Roux, Emilie
Delpech, Yann
Barranger, Emmanuel
Impact de la pandémie de COVID-19 sur les prises en charge pour cancer du sein et gynécologique
title Impact de la pandémie de COVID-19 sur les prises en charge pour cancer du sein et gynécologique
title_full Impact de la pandémie de COVID-19 sur les prises en charge pour cancer du sein et gynécologique
title_fullStr Impact de la pandémie de COVID-19 sur les prises en charge pour cancer du sein et gynécologique
title_full_unstemmed Impact de la pandémie de COVID-19 sur les prises en charge pour cancer du sein et gynécologique
title_short Impact de la pandémie de COVID-19 sur les prises en charge pour cancer du sein et gynécologique
title_sort impact de la pandémie de covid-19 sur les prises en charge pour cancer du sein et gynécologique
topic Article Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690308/
https://www.ncbi.nlm.nih.gov/pubmed/33358012
http://dx.doi.org/10.1016/j.bulcan.2020.10.013
work_keys_str_mv AT gossetmarie impactdelapandemiedecovid19surlesprisesenchargepourcancerduseinetgynecologique
AT galjocelyn impactdelapandemiedecovid19surlesprisesenchargepourcancerduseinetgynecologique
AT schiapparenaud impactdelapandemiedecovid19surlesprisesenchargepourcancerduseinetgynecologique
AT dejodemagali impactdelapandemiedecovid19surlesprisesenchargepourcancerduseinetgynecologique
AT foucheyves impactdelapandemiedecovid19surlesprisesenchargepourcancerduseinetgynecologique
AT alazetfanny impactdelapandemiedecovid19surlesprisesenchargepourcancerduseinetgynecologique
AT rouxemilie impactdelapandemiedecovid19surlesprisesenchargepourcancerduseinetgynecologique
AT delpechyann impactdelapandemiedecovid19surlesprisesenchargepourcancerduseinetgynecologique
AT barrangeremmanuel impactdelapandemiedecovid19surlesprisesenchargepourcancerduseinetgynecologique